Showing results (961-970 of 1,341) with videos related to

Sort By:
Pageof 135
Neuro-Oncology Advances|April 23, 2025
Outcomes in patients with multiple sclerosis and solid organ cancers treated with immune checkpoint inhibitorsChanawee Hirunpattarasilp, Pingfu Fu, Seunghee Park Margevicius, et al.
Neuro-Oncology Advances|April 7, 2025
Current trends in the allocation of National Institute of Health funding of brain tumor researchNoah L A Nawabi, Brian F Saway, Rohan Jha, et al.
Neuro-Oncology Advances|March 14, 2025
Functional connectivity between tumor region and resting-state networks as imaging biomarker for overall survival in recurrent gliomas diagnosed by O-(2-[18F]fluoroethyl)-l-tyrosine PETMichel Friedrich, Jan-Michael Werner, Joachim P Steinbach, et al.
Neuro-Oncology Advances|March 7, 2025
Size matters: Early progression of melanoma brain metastases after treatment with immune checkpoint inhibitorsSophie H A E Derks, Li Shen Ho, Stephan R Koene, et al.
Neuro-Oncology Advances|June 12, 2024
Effective re-induction regimen for children with recurrent medulloblastomaKatrina O'Halloran, Sheetal Phadnis, Gregory K Friedman, et al.
Neuro-Oncology Advances|June 14, 2024
Is Gamma Knife surgery, omitting adjunct whole brain radiation treatment, feasible for patients with 20 or more brain metastases?Sherry Liu Jiani, Bengt Karlsson, Balamurugan Vellayappan, et al.
Neuro-Oncology Advances|June 7, 2024
Pulsed reduced-dose rate re-irradiation for patients with recurrent grade 2 gliomasColin M Harari, Adam R Burr, Brett A Morris, et al.
Neuro-Oncology Advances|June 18, 2024
Matrix metalloproteinase 9: An emerging biomarker for classification of adherent vestibular schwannomaHan T N Nguyen, Bailey H Duhon, Hsuan-Chih Kuo, et al.
Neuro-Oncology Advances|May 27, 2024
Limited capability of MRI radiomics to predict primary tumor histology of brain metastases in external validationQuirin D Strotzer, Thomas Wagner, Pia Angstwurm, et al.
Neuro-Oncology Advances|December 15, 2025
Pediatric H3 K27-altered diffuse midline gliomas may consist of two clinically relevant subsets based on patient age and molecular genetic profileYufan Yang, Nitin Wadhwani, Yuki Aoi, et al.
Pageof 135